Views & Analysis 10 trends shaping pharma's future New technologies coming along to disrupt the pharma industry.
Views & Analysis Adding value with medical-grade wearables The factors to consider when developing medical-grade wearables.
News Lilly strikes $1.9bn kidney disease alliance with Ascidian In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
